CM Life Sciences III Inc.
CM Life Sciences III Inc. (CMLT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmlt · pe ratio · data through Jun 8, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CM Life Sciences III Inc.You CMLT | $4.2B | N/A | — | — |
 CM Life Sciences II Inc. CMII | $2.0B | N/A | — | — |
 EVgo, Inc. EVGO | $653M | N/A | — | -$0.31 |
 Forest Road Acquisition Corp. FRX | $3.7B | N/A | — | -$0.41 |
 Gores Holdings VI, Inc. GHVI | $4.2B | N/A | — | -$0.80 |
 GreenVision Acquisition Corp. GRNV | $3.8B | 1080.45x | — | $0.01 |
 Holicity Inc. HOL | $3.3B | N/A | — | -$0.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CM Life Sciences III Inc. (CMLT) measures how much investors pay for each dollar of the company's trailing earnings. CMLT's current PE ratio of N/A is calculated by dividing its stock price of $8.69 by its TTM earnings per share of —.
Frequently asked questions
CMLT pe ratio · 6 questionsCMLT's current PE ratio is N/A as of 2026-06-08, based on a stock price of $8.69 and TTM EPS of —. Data sourced from Financial Modeling Prep via CMLT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CM Life Sciences III Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08